• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATP13A2/PARK9基因缺陷既不会导致溶酶体损伤,也不会改变SH-SY5Y细胞中α-突触核蛋白的代谢。

ATP13A2/PARK9 Deficiency Neither Cause Lysosomal Impairment Nor Alter α-Synuclein Metabolism in SH-SY5Y Cells.

作者信息

Bae Eun-Jin, Lee Cheolsoon, Lee He-Jin, Kim Seokjoong, Lee Seung-Jae

机构信息

Department of Biomedical Science and Technology, School of Medicine, Konkuk University, Seoul 143-701, Korea. ; Institute of Biomedical Science and Technology, School of Medicine, Konkuk University, Seoul 143-701, Korea.

Institute of Biomedical Science and Technology, School of Medicine, Konkuk University, Seoul 143-701, Korea. ; Department of Anatomy, School of Medicine, Konkuk University, Seoul 143-701, Korea.

出版信息

Exp Neurobiol. 2014 Dec;23(4):365-71. doi: 10.5607/en.2014.23.4.365. Epub 2014 Dec 12.

DOI:10.5607/en.2014.23.4.365
PMID:25548536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4276807/
Abstract

Parkinson's disease is a multifactorial disorder with several genes linked to the familial types of the disease. ATP13A2 is one of those genes and encode for a transmembrane protein localized in lysosomes and late endosomes. Previous studies suggested the roles of this protein in lysosomal functions and cellular ion homeostasis. Here, we set out to investigate the role of ATP13A2 in lysosomal function and in metabolism of α-synuclein, another PD-linked protein whose accumulation is implicated in the pathogenesis. We generated non-sense mutations in both copies of ATP13A2 gene in SH-SY5Y human neuroblastoma cells. We examined lysosomal function of ATP13A2-/- cells by measuring the accumulation of lysosomal substrate proteins, such as p62 and polyubiquitinated proteins, induction of acidic compartments, and degradation of ectopically introduced dextran. None of these measures were altered by ATP13A2 deficiency. The steady-state levels of α-synuclein in cells or secretion of this protein were unaltered either in ATP13A2-/- compared to the normal cells. Therefore, the proposed roles of ATP13A2 in lysosomal functions may not be generalized and may depend on the cellular context. The ATP13A2-/- cells generated in the current study may provide a useful control for studies on the roles of PD genes in lysosomal functions.

摘要

帕金森病是一种多因素疾病,有多个基因与该疾病的家族型相关。ATP13A2是其中一个基因,编码一种定位于溶酶体和晚期内体的跨膜蛋白。先前的研究表明该蛋白在溶酶体功能和细胞离子稳态中发挥作用。在此,我们着手研究ATP13A2在溶酶体功能以及α-突触核蛋白代谢中的作用,α-突触核蛋白是另一种与帕金森病相关的蛋白,其积累与发病机制有关。我们在SH-SY5Y人神经母细胞瘤细胞的ATP13A2基因的两个拷贝中产生了无义突变。我们通过测量溶酶体底物蛋白(如p62和多聚泛素化蛋白)的积累、酸性区室的诱导以及异位引入的葡聚糖的降解来检测ATP13A2基因敲除细胞的溶酶体功能。ATP13A2基因缺陷并未改变这些指标中的任何一项。与正常细胞相比,ATP13A2基因敲除细胞中α-突触核蛋白的稳态水平或该蛋白的分泌也未改变。因此,ATP13A2在溶酶体功能中所提出的作用可能无法一概而论,可能取决于细胞环境。本研究中产生的ATP13A2基因敲除细胞可能为研究帕金森病相关基因在溶酶体功能中的作用提供有用的对照。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b0/4276807/3ee98539655b/en-23-365-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b0/4276807/4e027aacd6cd/en-23-365-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b0/4276807/62216f469899/en-23-365-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b0/4276807/c5ade74bb394/en-23-365-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b0/4276807/3ee98539655b/en-23-365-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b0/4276807/4e027aacd6cd/en-23-365-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b0/4276807/62216f469899/en-23-365-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b0/4276807/c5ade74bb394/en-23-365-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b0/4276807/3ee98539655b/en-23-365-g004.jpg

相似文献

1
ATP13A2/PARK9 Deficiency Neither Cause Lysosomal Impairment Nor Alter α-Synuclein Metabolism in SH-SY5Y Cells.ATP13A2/PARK9基因缺陷既不会导致溶酶体损伤,也不会改变SH-SY5Y细胞中α-突触核蛋白的代谢。
Exp Neurobiol. 2014 Dec;23(4):365-71. doi: 10.5607/en.2014.23.4.365. Epub 2014 Dec 12.
2
Deficiency of ATP13A2 leads to lysosomal dysfunction, α-synuclein accumulation, and neurotoxicity.ATP13A2 缺乏导致溶酶体功能障碍、α-突触核蛋白堆积和神经毒性。
J Neurosci. 2012 Mar 21;32(12):4240-6. doi: 10.1523/JNEUROSCI.5575-11.2012.
3
The Roles of Gene Mutations Leading to Abnormal Aggregation of α-Synuclein in Parkinson's Disease.导致α-突触核蛋白异常聚集的基因突变在帕金森病中的作用
Front Cell Neurosci. 2022 Jul 6;16:927682. doi: 10.3389/fncel.2022.927682. eCollection 2022.
4
Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.与帕金森病相关的人类PARK9/ATP13A2维持锌稳态并通过外泌体促进α-突触核蛋白外化。
Hum Mol Genet. 2014 Jun 1;23(11):2816-33. doi: 10.1093/hmg/ddu099. Epub 2014 Mar 6.
5
Neuropathology in an α-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein.α-突触核蛋白原纤维小鼠模型中的神经病理学发生与帕金森病相关的溶酶体 ATP13A2 蛋白无关。
Neurobiol Dis. 2024 Nov;202:106701. doi: 10.1016/j.nbd.2024.106701. Epub 2024 Oct 13.
6
Parkinson's disease-associated ATP13A2/PARK9 functions as a lysosomal H,K-ATPase.帕金森病相关 ATP13A2/PARK9 作为溶酶体 H,K-ATP 酶发挥作用。
Nat Commun. 2023 Apr 20;14(1):2174. doi: 10.1038/s41467-023-37815-z.
7
Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.帕金森病相关基因PARK9位点的遗传变异导致13A2型ATP酶功能受损。
Curr Protein Pept Sci. 2017;18(7):725-732. doi: 10.2174/1389203717666160311121534.
8
Increased Lysosomal Exocytosis Induced by Lysosomal Ca Channel Agonists Protects Human Dopaminergic Neurons from α-Synuclein Toxicity.溶酶体钙通道激动剂诱导的溶酶体胞吐作用可保护人多巴胺能神经元免受α-突触核蛋白毒性。
J Neurosci. 2019 Jul 17;39(29):5760-5772. doi: 10.1523/JNEUROSCI.3085-18.2019. Epub 2019 May 16.
9
The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.ATP13A2 在帕金森病中的作用:临床表型和分子机制。
Mov Disord. 2015 May;30(6):770-9. doi: 10.1002/mds.26243. Epub 2015 Apr 21.
10
The Parkinson-associated human P5B-ATPase ATP13A2 modifies lipid homeostasis.帕金森相关的人源 P5B-ATP 酶 ATP13A2 调节脂类稳态。
Biochim Biophys Acta Biomembr. 2019 Oct 1;1861(10):182993. doi: 10.1016/j.bbamem.2019.05.015. Epub 2019 May 24.

引用本文的文献

1
The Roles of Gene Mutations Leading to Abnormal Aggregation of α-Synuclein in Parkinson's Disease.导致α-突触核蛋白异常聚集的基因突变在帕金森病中的作用
Front Cell Neurosci. 2022 Jul 6;16:927682. doi: 10.3389/fncel.2022.927682. eCollection 2022.
2
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson's disease.脂质和免疫异常导致与年龄相关的神经退行性变和帕金森病。
J Neuroinflammation. 2019 Jul 22;16(1):153. doi: 10.1186/s12974-019-1532-2.
3
Endolysosomal dysfunction in Parkinson's disease: Recent developments and future challenges.

本文引用的文献

1
Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein.葡萄糖脑苷脂酶缺乏会增强α-突触核蛋白的细胞间传播。
Nat Commun. 2014 Aug 26;5:4755. doi: 10.1038/ncomms5755.
2
Identification of p.Gln858* in ATP13A2 in two EOPD patients and presentation of their clinical features.在两名早发性帕金森病(EOPD)患者中鉴定出ATP13A2基因的p.Gln858*突变,并展示其临床特征。
Neurosci Lett. 2014 Aug 8;577:106-11. doi: 10.1016/j.neulet.2014.06.023. Epub 2014 Jun 17.
3
Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.
帕金森病中的内溶酶体功能障碍:最新进展与未来挑战
Mov Disord. 2016 Oct;31(10):1433-1443. doi: 10.1002/mds.26797.
4
Non-cell-autonomous Neurotoxicity of α-synuclein Through Microglial Toll-like Receptor 2.α-突触核蛋白通过小胶质细胞Toll样受体2产生的非细胞自主性神经毒性
Exp Neurobiol. 2016 Jun;25(3):113-9. doi: 10.5607/en.2016.25.3.113. Epub 2016 Jun 8.
5
Genes associated with Parkinson's disease: regulation of autophagy and beyond.与帕金森病相关的基因:自噬及其他方面的调控
J Neurochem. 2016 Oct;139 Suppl 1(Suppl 1):91-107. doi: 10.1111/jnc.13266. Epub 2015 Sep 3.
与帕金森病相关的人类PARK9/ATP13A2维持锌稳态并通过外泌体促进α-突触核蛋白外化。
Hum Mol Genet. 2014 Jun 1;23(11):2816-33. doi: 10.1093/hmg/ddu099. Epub 2014 Mar 6.
4
Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases.细胞外 α-突触核蛋白:路易体病的一个新的关键因素。
Nat Rev Neurol. 2014 Feb;10(2):92-8. doi: 10.1038/nrneurol.2013.275. Epub 2014 Jan 28.
5
LRRK2 as a Potential Genetic Modifier of Synucleinopathies: Interlacing the Two Major Genetic Factors of Parkinson's Disease.LRRK2作为突触核蛋白病的潜在遗传修饰因子:连接帕金森病的两个主要遗传因素。
Exp Neurobiol. 2013 Dec;22(4):249-57. doi: 10.5607/en.2013.22.4.249. Epub 2013 Dec 31.
6
Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction.帕金森病相关的人类ATP13A2(PARK9)缺乏会导致锌稳态失衡和线粒体功能障碍。
Hum Mol Genet. 2014 Jun 1;23(11):2802-15. doi: 10.1093/hmg/ddt623. Epub 2014 Jan 7.
7
Zn²⁺ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation.由ATP13A2/PARK9缺失导致的锌离子稳态失衡会引发溶酶体功能障碍和α-突触核蛋白聚集。
Hum Mol Genet. 2014 Jun 1;23(11):2791-801. doi: 10.1093/hmg/ddt572. Epub 2013 Dec 13.
8
CATP-6, a C. elegans ortholog of ATP13A2 PARK9, positively regulates GEM-1, an SLC16A transporter.CATP-6是ATP13A2 PARK9的秀丽隐杆线虫直系同源物,正向调控SLC16A转运蛋白GEM-1。
PLoS One. 2013 Oct 9;8(10):e77202. doi: 10.1371/journal.pone.0077202. eCollection 2013.
9
Glucocerebrosidase, a new player changing the old rules in Lewy body diseases.葡萄糖脑苷脂酶,改变路易体病旧规则的新角色。
Biol Chem. 2013 Jul;394(7):807-18. doi: 10.1515/hsz-2012-0322.
10
Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits.Atp13a2 缺陷小鼠表现出神经元蜡样脂褐质沉积病,α-突触核蛋白积累有限,以及年龄依赖性感觉运动功能障碍。
Hum Mol Genet. 2013 May 15;22(10):2067-82. doi: 10.1093/hmg/ddt057. Epub 2013 Feb 7.